Neurofilament Light (NfL) Biological Role & Axonal Injury Kinetics

Neurofilaments are the core cylindrical intermediate filaments (~10 nm diameter) of the neuronal cytoskeleton, predominantly localized in long, myelinated subcortical and spinal axons. The intermediate filament core is an obligate heteropolymer consisting of Neurofilament Light (NfL, ~68 kDa), Medium (NfM, ~160 kDa), and Heavy (NfH, ~200 kDa) subunits assembled in a physiological 4:2:1 ratio. NfL provides the structural scaffold required to maintain radial axonal caliber, stabilize microtubule bundles, and preserve high-velocity saltatory conduction along the axon length.

Under normal physiological conditions, low steady-state levels of NfL enter the interstitial space during natural axonal remodeling. Following physical trauma, metabolic disruption, inflammatory demyelination, or toxic proteopathy, axonal membrane permeabilization and calpain-mediated proteolytic cleavage trigger an immediate release of soluble NfL. Released NfL diffuses into the brain interstitial fluid, equilibrates with the cerebrospinal fluid (CSF), and subsequently traverses into the peripheral venous circulation via arachnoid villi and the glymphatic bulk flow clearance pathway.

Why Circulating Blood NfL is the Benchmark Translational Biomarker

  • High Blood-to-CSF Fidelity: Peripheral plasma and serum NfL concentrations exhibit a robust linear correlation with paired CSF NfL (r = 0.88–0.94 across preclinical and translational cohorts), making longitudinal serial blood sampling a reliable surrogate for invasive lumbar punctures.
  • Etiology-Agnostic Structural Readout: While amyloid-beta or tau biomarkers indicate specific disease-defining proteopathies, NfL objectively reflects the actual rate and magnitude of active neuroaxonal structural breakdown.
  • Dynamic Pharmacodynamic Sensitivity: In preclinical candidate drug trials, successful neuroprotective interventions or remyelination therapies result in a prompt, measurable reduction in elevated blood NfL trajectories.
  • Evolutionary Epitope Homology: The central alpha-helical coiled-coil rod domain of NfL is conserved across human, non-human primate (NHP), and rodent species, allowing direct cross-species translation using identical monoclonal antibody pairs.